Dr Marie-Claude Morice (France)

Dr Marie-Claude Morice studied at the University of Medicine in Paris where she obtained her medical degree in 1973 and her Diploma in Specialized Cardiology Studies in 1975. In 1986, she was appointed Head of the Interventional Cardiology Department of the CCN, the  2nd largest PCI center in France in 1990.

Since 1995, she has been the Head of Interventional Cardiology at the Institut Cardiovasculaire Paris (Générale de Santé) the highest-volume PCI centers in the Greater Paris Area.

Dr Morice is a Fellow of the European Society of Cardiology and the American College of Cardiology and Honorary Professor of the Universidad Del Salvador in Buenos Aires.

She is regularly invited as a guest lecturer and chairperson at all major international Cardiology scientific sessions of the AHA, ACC and ESC as well as guest faculty and live case operator in all prominent Interventional Cardiology courses (TCT, TCTAP, TOPIC, CIT, SUMMIT, EuroPCR) in Europe, North and South America and Asia and a board member and Senior Consulting Adviser of EuroPCR. She is a co-editor for EuroIntervention and an invited reviewer for the Lancet, the NEJM, JAMA, Circulation, JACC, EHJ and others.

Dr Morice has been involved in multiple clinical research activities over the past 20 years resulting in more than 250 peer-reviewed publications.  She was voted Best Clinical Researcher in 1995 (Erasmus) and Cardiologist of the year in 1997. She was the co-founder of the French study group ‘Coronary Stenting Without Coumadin’, the Principal Investigator of the Ravel Trial, the Reality Study and the co PI of the  Syntax Trial in charge of the Left Main publications.

In 2013,  Dr Morice  was designated Best  Interventional Cardiologist in France by the French magazine  Capital, and in 2014 she received the CHIEN award during ASIA PCR and the  Geoffrey O. Hartzler Master Operator  Award at TCT 2014 for her career achievements.

Dr. Morice is a member of the executive committee of the Leaders Free, Compare Absorb and Senior trials. She has been a member of the Tokyo Valve Board of Directors since 2016, and of the PCR Clinical Research Course Board of Directors since 2015.

She gave the Gruntzig Lecture during the 2017 Scientific Sessions of the ESC.

Dr. Morice is co-organizer of the ARC HBR initiative